1.      Chang E.T., Zheng T., Weir E., Borowitz M., Mann R., Mueller N.  Regular aspirin use and reduced risk of Hodgkin’s lymphoma in a population-based case-control study. JNCI 96:305-315, 2004. 2.      Chang E.T., Zheng T., Lennette E.T., Weir E., Borowitz M., Mann R.B., Spiegelman D., Mueller N.E.  Heterogeneity of risk factors and antibody profiles in Epstein-Barr virus genome-positive and genome-negative Hodgkin’s lymphoma. J Infect Dis 189:2271-2281, 2004. 3.      Okayama, A., Stuver, S., Matsuoka, M., Ishizaki, J., Tanaka, G.-i., Kubuki, Y., Mueller, N., Yamaguchi, K., Hsieh, C-C., Tachibana, N., Tsubouchi, H. Role of HTLV-I proviral DNA load and clonality in the development of  adult T-cell leukemia/lymphoma in asymptomatic carriers.  Int J Cancer 110:621-625, 2004. 4.      Volkow, P., Velasco, S.R., Mueller, N., Sierra-Madero, G., Castillo, J.R., Mohar, A. Transfusion-associated HIV infection in Mexico related to paid blood donors’ HIV epidemic. Int J STD AIDS 15:337-342, 2004. 5.      Chang, E.T., Zheng, T., Weir, E., Borowitz, M., Mann, R., Spiegelman, D., Mueller, N. Childhood social environment and Hodgkin’s lymphoma in a population–based case-control study. Cancer Epi Biomarkers Prev 13:1361-1370, 2004. 6.      Matsuo K., Kusano A., Sugumar A., Nakamura S., Tajima K., Mueller N.E. Effect of hepatitis C virus infection on the risk of non-Hodgkin’s lymphoma: Analysis of epidemiological studies.  Cancer Sci 95:745-752, 2004.  7.      Hisada M., Stuver, S.O., Okayama, A., Li, H.-C., Sawada, T., Hanchard, B., Mueller, N.E. A persistent paradox of HTLV-I natural history: Parallel analyses of Japanese and Jamaican carriers.  J Infect Dis 190:1605-1609,2004. 

8.      Birmann B.M., Mueller N., Okayama A., Hsieh C.C., Tachibana N., Tsubouchi H., Lennette E.T., Harn D., Stuver S.  Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults.  Cancer Epidemiol Biomarkers Prev 13:1385-1391, 2004.

9.      Matsuo, K., Hamajima, N., Suzuki, R., Ogura, M., Kagami, Y., Taji, H., Mueller, N.E., Nakamura, S., Seto, M., Morishima, Y., Tajima, K. Folate and methionine-metabolizing enzyme gene polymorphisms change susceptibility with regard to malignant lymphoma. Am J Hematology 77:351-357, 2004.  10.  Gao, G., Stuver, S.O., Okayama, A., Tsubouchi, H., Mueller, N.E., Tabor, E. The minimum number of clones necessary to sequence in order to obtain the maximum information about hepatitis C virus quasispecies: A comparison of cases with and without liver cancer. J Viral Hepatitis 12:46-50,2005.  11.  Tanaka G.-i., Okayama, A., Watanabe, T., Arisawa, S., Stuver, S., Mueller, N., Hsieh, C.-c., Tsubouchi, H.  The clonal expansion of HTLV-I infected cells: A comparison between seroconverters and long-term carriers. J Infect Dis 191:1140-1147, 2005. 12.  Peters E.S., McClean M.D., Liu M., Eisen E.A., Mueller N., Kelsey K.T.  The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. .  Cancer Epidemiol Biomarkers Prev  14:476-82, 2005. 13.  Orjuela M., Titievsky L., Liu X. Ramirez-Ortiz M., Ponce-Castaneda M., Lecona E., Molina E., Beaverson K., Abramson D., Mueller N.  Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma. Cancer Epidemiol Biomarkers Prev 14:1433-1400. 2005. 14.  Stratigos, A.J., Malanos, D., Touloumi, G., Antoniou, A., Potouridou, E., Polydorou, D., Katsambas, A.D., Whitby, D., Mueller, N., Stratigos JD, Hatzakis, A. Association of clinical progression in classic Kaposi’s Sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers.  Arch Dermatol 141:1421-1426, 2005. 15.  Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez-Avila M, Lazcano-Ponce E. Determinants of prevalence, acquisition and persistence of human papillomavirus in healthy Mexican males.  Cancer Epidemiol Biomarkers Prev 14:1710-1716, 2005. 16.  Taniguchi Y., Nosaka K., Yasunaga J.-i., Maeda M., Mueller N., Okayama A., Matsuoka M. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.  Retrovirology. 2:64, 2005. 17.  Birmann B.M., Mueller N.E., Okayama A., Hsieh C.C., Tsubouchi H., Harn D., Stuver S.O. Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I. J Med Virology 78:770-779, 2006. 18.  Suruki R., Mueller N., Hayashi K., Harn D., DeGruttola V., Raker C., Tsubouchi H., Stuver S. O. Host immune status and incidence of hepatocellular carcinoma among subjects infected with hepatitis C virus: A nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev 15:2521-2525, 2006. 13. Mueller, N.E., Birmann, B.M., Parsonnet, J., Schiffman, M.H., Stuver, S.O. Infectious Agents. In Schottenfeld, D., Fraumeni, J.F., Jr. (eds.) Cancer Epidemiology and Prevention.  Third Edition. Oxford University Press, 2006, pp. 507-548.  

14. Mueller, N.E., Grufferman, S. Hodgkin Lymphoma. In Schottenfeld, D., Fraumeni, J.F., Jr. (eds.) Cancer Epidemiology and Prevention.  Third Edition. Oxford University Press, 2006, pp.872-897.

 15. Mueller, N.E,. Grufferman S., Chang, E.T.  The Epidemiology of Hodgkin Lymphoma.  In Hoppe, R., Mauch, P., Armitage, J., Diehl, V., Weiss, L. (eds.) Hodgkin’s Disease. Second Edition. Lippincott-Raven , New York, 2007, pp.7-24.